Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
+0.33 (3.86%)
At close: May 17, 2024, 4:00 PM
+0.01 (0.11%)
After-hours: May 17, 2024, 6:12 PM EDT

Acrivon Therapeutics Statistics

Total Valuation

ACRV has a market cap or net worth of $273.26 million. The enterprise value is $167.31 million.

Market Cap 273.26M
Enterprise Value 167.31M

Important Dates

The last earnings date was Tuesday, May 14, 2024, before market open.

Earnings Date May 14, 2024
Ex-Dividend Date n/a

Share Statistics

ACRV has 30.88 million shares outstanding. The number of shares has increased by 3.06% in one year.

Shares Outstanding 30.88M
Shares Change (YoY) +3.06%
Shares Change (QoQ) +1.13%
Owned by Insiders (%) 22.87%
Owned by Institutions (%) 69.45%
Float 12.13M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.53
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.40, with a Debt / Equity ratio of 0.04.

Current Ratio 12.40
Quick Ratio n/a
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -49.70% and return on invested capital (ROIC) is -62.60%.

Return on Equity (ROE) -49.70%
Return on Assets (ROA) -45.00%
Return on Capital (ROIC) -62.60%
Revenue Per Employee n/a
Profits Per Employee -$1.11M
Employee Count 58
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.15% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -34.15%
50-Day Moving Average 7.85
200-Day Moving Average 6.88
Relative Strength Index (RSI) 53.15
Average Volume (30 Days) 788,296

Short Selling Information

The latest short interest is 1.08 million, so 3.51% of the outstanding shares have been sold short.

Short Interest 1.08M
Short Previous Month 1.03M
Short % of Shares Out 3.51%
Short % of Float 8.94%
Short Ratio (days to cover) 0.53

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -70.38M
Pretax Income -64.12M
Net Income -64.12M
EBITDA -62.67M
EBIT -64.12M
Earnings Per Share (EPS) -$2.89
Full Income Statement

Balance Sheet

The company has $110.39 million in cash and $4.45 million in debt, giving a net cash position of $105.95 million or $3.43 per share.

Cash & Cash Equivalents 110.39M
Total Debt 4.45M
Net Cash 105.95M
Net Cash Per Share $3.43
Equity / Book Value 107.98M
Book Value Per Share 3.50
Working Capital 103.10M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$48.37 million and capital expenditures -$2.08 million, giving a free cash flow of -$50.45 million.

Operating Cash Flow -48.37M
Capital Expenditures -2.08M
Free Cash Flow -50.45M
FCF Per Share -$2.23
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ACRV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.06%
Shareholder Yield -3.06%
Earnings Yield -23.46%
FCF Yield -18.46%

Analyst Forecast

The average price target for ACRV is $24.14, which is 171.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target $24.14
Price Target Difference 171.54%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 1.15%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 2